A labelling system improves parental comfort and willingness to use topical corticosteroids for paediatric atopic dermatitis.

Parents of children with AD confirmed significant concerns and demonstrated poor knowledge regarding TCS use. Our findings suggest that a simple labelling system may improve TCS adherence. Future work to test refined label prototypes and evaluating their impact on adherence and correct use is needed.